ULTRAGENYX PHARMACEUTICAL INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -51.9% | -51.9% | -45.5% |
| FY2017 | -78.8% | -78.8% | -61.6% |
| FY2018 | -32.5% | -32.5% | -27.5% |
| FY2019 | -61.6% | -61.6% | -35.5% |
| FY2020 | -16.2% | -16.2% | -10.6% |
| FY2021 | -49.2% | -49.2% | -29.8% |
| FY2022 | -201.0% | -201.0% | -45.8% |
| FY2023 | -220.7% | -220.7% | -40.7% |
| FY2024 | -223.1% | -223.1% | -37.9% |
| FY2025 | 718.8% | 718.8% | -37.5% |